 |
市场调查报告书
商品编码
1181766
GMP 合同製造市场：按产品类型、应用、方法、最终用户、地区划分——规模、份额、展望、机会分析，2022-2030 年GMP Protein Contract Manufacturing Market, by Product Type, by Application, by Method, by End User and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 |
||||||
价格
简介目录
GMP 蛋白质（大肠桿菌）可能会或可能不会使用无动物工艺生产，具体取决于蛋白质的特性。 重组蛋白是由克隆在支持基因表达和信使 RNA 翻译的系统中的基因重组 DNA 编码的蛋白质。 通过重组 DNA 技术对基因进行修饰可能会导致突变蛋白的表达。 在细菌中共表达的蛋白质没有磷酸化或糖基化等翻译后修饰。 作为药物生产和销售的重组蛋白包括 Humulin、Hematrope、Avonex、Kogenate 和 Pulmozyme。
市场动态
预计在预测期内，市场上产品发布的增加将推动全球 GMP 蛋白（大肠桿菌）合同製造市场的增长。 例如，2022 年 6 月，优质生命科学研究试剂和服务提供商 AMSBIO 宣布推出用于细胞治疗应用的 Stem Fit Protein 系列重组蛋白。 Stemfit Protein 系列包括在胰腺、心臟、肾臟、血液和免疫细胞中胚胎干细胞 (ES) 和诱导多能细胞 (iPS) 的分化中发挥重要作用的重组蛋白。 此外，2021 年 9 月，为生命科学研究提供抗体、免疫试剂盒和重组蛋白的 Aviva System Biology 将推出半订单 GMP 等级组，供生命科学家进行基础和临床前研究。我们宣布推出一个新的替代蛋白质组合。 我们的 Protein on Demand 产品组合包含超过 300,000 种蛋白质，可让您的研究团队快速获得定制蛋白质的中小规模生产。
这项研究的主要特点
- 本报告对全球 GMP 蛋白（大肠桿菌）合同製造市场进行了深入分析，显示了预测期内（2022-2030 年）的市场规模和復合年增长率 (CAGR%)，其中 2021 年为基准年。报价。
- 它揭示了不同细分市场的潜在收入机会，并为该市场概述了一个有吸引力的投资建议矩阵。
- 它还提供了有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景、主要参与者采用的竞争战略等方面的重要见解。
- 根据以下参数对全球 GMP 蛋白质（大肠桿菌）合同製造市场的主要参与者进行了介绍 - 公司亮点、产品组合、主要亮点、财务业绩和战略。
- 本研究涵盖的主要公司包括 Merck & Co., Inc.、Thermo Fisher Scientific Inc.、Abcam plc、GenScript、Biomay AG、SOL GROUP、Proteintech Group, Inc.、Nordmark Pharma GmbH、Sino Biological、 Inc., Sino Biological, Inc., Abnova Corporation, Eurofins Scientific, Arcline Investment Management LP, Abgenex, Xpress Biologics, Avid Bioservices Inc., Bio-Techne, Northway Biotech, Aldevron, Institut Merieux, PerkinElmer Inc., Creative BioMart, Profacgen , ProBioGen AG, 53Biologics, Leadgene Biomedical, Inc., Ajinomoto Bio-Pharma, FUJIFILM Diosynth Biotechnologies, Avioq, Inc., Biovian Oy, KBI Biopharma, GTP Bioways, QIAGEN, Suzhou Novoprotein Technology Co., Ltd., ACROBiosystems, Kactus, F. Hoffmann-La Roche Ltd. 和 Enzo Life Sciences, Inc.
- 这份报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。我猜。
- 全球 GMP 蛋白质（大肠桿菌）合同製造市场报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
- 利益相关者将能够通过用于分析全球 GMP 蛋白质（大肠桿菌）合同製造市场的各种战略矩阵来促进他们的决策。
内容
第 1 章目的和先决条件
- 调查目的
- 先决条件
- 缩写说明
第二章市场展望
- 报告内容
- 市场定义和范围
- 执行摘要
- 按产品类型划分的市场概况
- 市场概况：按应用分类
- 市场概况：按方法
- 市场概况：按最终用户分类
- 市场概况：按地区
- 连贯机会图 (COM)
第3章市场动态、规律及趋势分析
- 市场动态
- 司机
- 约束因素
- 市场机会
- 影响分析
- 害虫分析
- 波特分析
- 主要发展状况
- 监管场景
- 收购/合同方案
- 品牌映射
第 4 章全球 GMP 蛋白（大肠桿菌）合同製造市场：冠状病毒 (COVID-19) 大流行的影响
- 总体影响
- 对供需的影响
- COVID-19 对市场的影响
第 5 章全球 GMP 蛋白质（大肠桿菌）合同製造市场：按产品类型，2017-2030
- 细胞因子
- 生长因子
- 酵素
- DNA聚合□
- 蛋白□
- 胰蛋白□
- 核酸□
- IVT□
- 其他
- 荷尔蒙
- 抗原
- 其他
第 6 章全球 GMP 蛋白质（大肠桿菌）合同製造市场：按应用分类，2017-2030
- 基因治疗
- 细胞疗法
第 7 章全球 GMP 蛋白质（大肠桿菌）合同製造市场：按方法，2017-2030
- 体内
- 离体
第 8 章全球 GMP 蛋白质（大肠桿菌）合同製造市场：按最终用户分类，2017-2030
- 生物技术公司、製药公司
- 学术和研究机构
- 委託研究机构
- 其他
第 9 章全球 GMP 蛋白质（大肠桿菌）合同製造市场：按地区划分，2017-2030
- 北美
- 美国
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲地区
- 欧洲
- 英国
- 德国
- 意大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲
- 亚太地区
- 中国
- 印度
- 日本
- 东盟
- 澳大利亚
- 韩国
- 其他亚太地区
- 中东
- 海湾合作委员会
- 以色列
- 其他中东地区
- 非洲
- 北非
- 中非
- 南非
第10章竞争格局
- Merck & Co., Inc
- Thermo Fisher Scientific Inc.
- Abcam plc
- GenScript
- Biomay AG
- SOL GROUP
- Proteintech Group, Inc.
- Nordmark Pharma GmbH
- Sino Biological, Inc.
- Kaneka Eurogentec S.A.
- Abnova Corporation
- Eurofins Scientific
- Arcline Investment Management LP.
- Abgenex
- Xpress Biologics
- Avid Bioservices, Inc.
- Bio-Techne
- Northway Biotech
- Aldevron
- Institut Merieux
- PerkinElmer Inc.
- Creative BioMart
- Profacgen
- ProBioGen AG
- 53Biologics
- Leadgene Biomedical, Inc.
- Ajinomoto Bio-Pharma
- FUJIFILM Diosynth Biotechnologies
- Avioq, Inc
- Biovian Oy
- KBI Biopharma
- GTP Bioways
- QIAGEN
- Suzhou Novoprotein Technology Co., Ltd
- ACROBiosystems
- Kactus
- F. Hoffmann-La Roche Ltd.
- Enzo Life Sciences, Inc.
第 11 章章节
- 调查方法
- 关于出版商
简介目录
Product Code: CMI5433
GMP Protein (E. coli) may or may not be manufactured using animal-free processes depending on the characteristics of the protein. Recombinant Protein is a protein encoded by a gene recombinant DNA that has been cloned in a system that supports the expression of the gene and translation of messenger RNA. Modification of the gene by recombinant DNA technology can lead to the expression of a mutant protein. Proteins co-expressed in bacteria will not possess post-translational modifications, e.g. phosphorylation or glycosylation. Some of the recombinant proteins which were produced and commercialized in medications are Humulin, Hematrope, Avonex, Kogenate, Pulmozyme and others.
Market Dynamics
Increasing launches of products in the market is expected to drive the growth of the global GMP protein (E. coli) contract manufacturing market over the forecast period. For instance, in June 2022, AMSBIO, a provider of quality life science research reagents and services, announced the launch of its Stem Fit Protein range of recombinant proteins for cell therapy applications. The Stem Fit Protein range includes recombinant proteins that play key roles in differentiating Embryonic Stem (ES) and induced Pluripotent Cells (iPS) in the pancreas, heart, kidney, blood, and immune cells. Moreover, in September 2021, Aviva Systems Biology, a company providing antibodies, immunoassay kits, and recombinant proteins for life science research, announced the launch of its new Protein on Demand semi-custom GMP grade recombinant protein portfolio for life scientists conducting basic research and preclinical studies. The Protein on Demand portfolio of over 300,000 proteins allows rapid access to small- to mid-scale production of customized proteins for research teams.
Key features of the study:
- This report provides an in-depth analysis of the global GMP protein (E. coli) contract manufacturing market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global GMP protein (E. coli) contract manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Merck & Co., Inc., Thermo Fisher Scientific Inc., Abcam plc, GenScript, Biomay AG, SOL GROUP, Proteintech Group, Inc., Nordmark Pharma GmbH, Sino Biological, Inc., Sino Biological, Inc., Abnova Corporation, Eurofins Scientific, Arcline Investment Management LP, Abgenex, Xpress Biologics, Avid Bioservices Inc, Bio-Techne, Northway Biotech, Aldevron, Institut Merieux, PerkinElmer Inc., Creative BioMart, Profacgen, ProBioGen AG, 53Biologics, Leadgene Biomedical, Inc., Ajinomoto Bio-Pharma, FUJIFILM Diosynth Biotechnologies, Avioq, Inc, Biovian Oy, KBI Biopharma, GTP Bioways, QIAGEN, Suzhou Novoprotein Technology Co., Ltd., ACROBiosystems, Kactus, F. Hoffmann-La Roche Ltd., and Enzo Life Sciences, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global GMP protein (E. coli) contract manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global GMP protein (E. coli) contract manufacturing market.
Detailed Segmentation:
- Global GMP Protein (E. coli) Contract Manufacturing Market, By Product Type:
- Cytokines
- Growth Factors
- Enzymes
- DNA polymerase
- Protease
- Trypsin
- Nuclease
- Benzonase
- Cas9 Nucleases
- Others
- IVT Enzymes
- Others
- Hormones
- Antigens
- Others
- Global GMP Protein (E. coli) Contract Manufacturing Market, By Application:
- Gene Therapy
- Cell Therapy
- Global GMP Protein (E. coli) Contract Manufacturing Market, By Method:
- In-Vivo
- Ex-Vivo
- Global GMP Protein (E. coli) Contract Manufacturing Market, By End User:
- Biotechnology and Pharmaceutical Companies
- Academic & Research Institutes
- Contract Research Organizations
- Others
- Global GMP Protein (E. coli) Contract Manufacturing Market, By Region:
- North America
- By Country
- U.S.
- Canada
- Latin America
- By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Country
- GCC
- Israel
- Rest of Middle East
- Africa
- By Region/Country
- South Africa
- Central Africa
- North Africa
- North America
- Company Profiles
- Merck & Co., Inc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Abcam plc
- GenScript
- Biomay AG
- SOL GROUP
- Proteintech Group, Inc.
- Nordmark Pharma GmbH
- Sino Biological, Inc.
- Abnova Corporation
- Eurofins Scientific
- Arcline Investment Management LP
- Abgenex
- Xpress Biologics
- Avid Bioservices Inc
- Bio-Techne
- Northway Biotech
- Aldevron
- Institut Merieux
- PerkinElmer Inc.
- Creative BioMart
- Profacgen
- ProBioGen AG
- 53Biologics
- Leadgene Biomedical, Inc.
- Ajinomoto Bio-Pharma
- FUJIFILM Diosynth Biotechnologies
- Avioq, Inc
- Biovian Oy
- KBI Biopharma
- GTP Bioways
- QIAGEN
- Suzhou Novoprotein Technology Co., Ltd.
- ACROBiosystems
- Kactus
- F. Hoffmann-La Roche Ltd.
- Enzo Life Sciences, Inc.
- Merck & Co., Inc.
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Method
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- PEST Analysis
- Porter's Analysis
- Key Developments
- Regulatory Scenario
- Acquisition and Agreement Scenario
- Brand Mapping
4. Global GMP Protein (E. coli) Contract Manufacturing Market- Impact of Coronavirus (Covid-19) Pandemic
- Overall Impact
- Impact on Supply and Demand
- COVID-19 Impact on the market
5. Global GMP Protein (E. coli) Contract Manufacturing Market, By Product Type, 2017 - 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Cytokines
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Growth Factors
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Enzymes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- DNA polymerase
- Protease
- Trypsin
- Nuclease
- Benzonase
- Cas9 Nucleases
- Others
- IVT Enzymes
- Others
- Hormones
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Antigens
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
6. Global GMP Protein (E. coli) Contract Manufacturing Market, By Application, 2017 - 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Gene Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Cell Therapy
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
7. Global GMP Protein (E. coli) Contract Manufacturing Market, By Method, 2017 - 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- In-Vivo
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Ex-Vivo
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
8. Global GMP Protein (E. coli) Contract Manufacturing Market, By End User, 2017 - 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
- Biotechnology and Pharmaceutical Companies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Contract Research Organizations
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
9. Global GMP Protein (E. coli) Contract Manufacturing Market, By Region, 2017 - 2030, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Merck & Co., Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Thermo Fisher Scientific Inc.
- Abcam plc
- GenScript
- Biomay AG
- SOL GROUP
- Proteintech Group, Inc.
- Nordmark Pharma GmbH
- Sino Biological, Inc.
- Kaneka Eurogentec S.A.
- Abnova Corporation
- Eurofins Scientific
- Arcline Investment Management LP.
- Abgenex
- Xpress Biologics
- Avid Bioservices, Inc.
- Bio-Techne
- Northway Biotech
- Aldevron
- Institut Merieux
- PerkinElmer Inc.
- Creative BioMart
- Profacgen
- ProBioGen AG
- 53Biologics
- Leadgene Biomedical, Inc.
- Ajinomoto Bio-Pharma
- FUJIFILM Diosynth Biotechnologies
- Avioq, Inc
- Biovian Oy
- KBI Biopharma
- GTP Bioways
- QIAGEN
- Suzhou Novoprotein Technology Co., Ltd
- ACROBiosystems
- Kactus
- F. Hoffmann-La Roche Ltd.
- Enzo Life Sciences, Inc.
11. Section
- Research Methodology
- About Us
02-2729-4219
+886-2-2729-4219
世界及美国的胚移植用培养液市场:2024-2030年
基因治疗市场机会与预测（2017-2031）：按类型、载体、基因传递方法、应用、给药途径、最终用户和地区
到 2030 年的基因预测工具市场预测：按组件、应用、最终用户和地区进行的全球分析
基因治疗市场，按载体类型、按基因类型、按治疗、按应用、按国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测
基因治疗市场规模、份额、趋势分析报告：按适应症、载体类型、地区、细分市场预测，2024-2030
全球基因治疗市场：按类型、载体、治疗领域、递送方法、地区 - 预测（~2028）
基因治疗市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按载体类型、交付方法、适应症、地区、竞争细分
安德森-塔维尔症候群市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按疾病类型、按地区和竞争的配销通路细分
遗传谱系市场 - 2018-2028 年全球产业规模、份额、趋势、机会和预测，按测试类型、按应用、最终用户、地区和竞争细分
基因预测工具市场-按组件（软体、服务）、应用（药物发现和设计、诊断）、最终用户（研究和学术机构、生物技术和製药公司、医院和诊所）、全球预测（2023-2032）
▼